Cancer Therapeutics Market Is Expected to Reach USD 170.63 Billion by 2022, at a CAGR of 9.2% from 2016 to 2022
According to the report, “Cancer Therapeutics Market, by Therapeutics (Chemotherapy, Hormonal, and Immunotherapy), Types (Prostate Cancer, Blood Cancer, Lung Cancer, Skin Cancer, Gastrointestinal Cancer, and Breast Cancer), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022”, the market for cancer therapeutics is set to witness significant growth during the forecast period.
Chicago, IL -- (SBWire) -- 03/01/2017 --The cancer therapeutics market report forecasts the growth and revenue trends for the global market. It also offers in-depth analysis of the market drivers, restraints, market share, segmentation, and the key market players.
Leaf through our data-driven infographic report on Global Cancer Therapeutics Market:
Early Buyers can avail 20% discount & 100% customization on this report, for the month of October.
According to the cardiovascular therapeutics market report, the global market is expected to grow at a healthy rate during the forecast period. The increasing prevalence of different types of cancer, the increasing research activities from the multinational companies, the growth in medical tourism, advancing techniques, quick approvals from the drug administration authorities from around the world, and such others are the major driving factors for this market. According to the report, the market segments, such as immunotherapy is expected to witness an impressive rise in demand from different geographic regions. The increased focus on the targeted cancer therapies is also expected to play a significant role in the overall development of the global market.
Immunotherapy to become the largest therapeutic segment
The report segments the cancer therapeutics market by therapeutics, types of cancer, and the major geographic regions. The types of cancer include blood cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, and skin cancer. The therapeutics segments include hormonal, chemotherapy, and immunotherapy. The major geographic regions of the market include Europe, North America, Asia, Pacific, North America, and the Rest of the World. According to the report, the developing regions of the world are expected to provide potential growth opportunities for the global market. The Asia-Pacific region is expected to grow at the fastest rate during the forecast period.
Request a Sample: https://www.scalarmarketresearch.com/request-sample.php?id=183
The key players included in the cancer therapeutics market report include Amgen, Inc., Celgene Corporation, Eli Lilly and Company, F.Hoffmann la Roche, GlaxoSmithKline PLC, Johnson and Johnson, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Sanofi SA, and such others. The report anticipates impressive growth for the key market players during the forecast period. This growth is concentrated in the emerging markets. The regions like Asia-Pacific and North America are expected to create strong growth opportunities for the key players in this market.
Browse Related Reports:
Prescription Pharmaceuticals Market - Therapeutic Segments, Formulations, Geography (2013 - 2020)
Orphan Drugs Market - Indication Types and Geography (2014 - 2022)
About Scalar Market Research
Scalar Market Research Inc. aspires to assist organizations from around the world to achieve their business goal with premium market research reports and consulting services. Our real-time industry tracking with the help of advanced analytics offers a crystal clear view of all the activities in niche markets. Our team, with thorough global understanding, works relentlessly to gather the necessary market insights, including customer analysis, competitions and global forecast.
Find out more about our services at: www.scalarmarketresearch.com
8770 W Bryn Mawr Ave.,
Chicago, IL 60631
Tel.: +1-800-213-5170 (U.S./Canada Toll-free)
Media Relations Contact
Vice President -- Marketing
Scalar Market Research
View this press release online at: http://rwire.com/776805